View source for DSM IP ASSETS B.V. (20240263172). CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) simplified abstract

=CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)=


==Organization Name==

[[:Category:DSM IP ASSETS B.V.|DSM IP ASSETS B.V.]]


[[Category:DSM IP ASSETS B.V.]]

==Inventor(s)==

[[:Category:Johannes Andries Roubos of Echt (NL)|Johannes Andries Roubos of Echt (NL)]][[Category:Johannes Andries Roubos of Echt (NL)]]

[[:Category:Rene Verwaal of Echt (NL)|Rene Verwaal of Echt (NL)]][[Category:Rene Verwaal of Echt (NL)]]

[[:Category:Brenda Vonk of Echt (NL)|Brenda Vonk of Echt (NL)]][[Category:Brenda Vonk of Echt (NL)]]

==CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240263172 titled 'CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)

'''Simplified Explanation:'''
The patent application relates to a CRISPR transient expression construct (CTEC) for a genome editing system in the fields of molecular biology and cell biology.

'''Key Features and Innovation:'''
* CRISPR transient expression construct (CTEC) for genome editing
* Specific application in molecular biology and cell biology
* Enhances precision and efficiency of genome editing systems

'''Potential Applications:'''
The technology can be used in research laboratories, biotechnology companies, and pharmaceutical industries for precise genome editing in various organisms.

'''Problems Solved:'''
The technology addresses the challenges of achieving precise and efficient genome editing in molecular and cell biology research.

'''Benefits:'''
* Improved precision and efficiency in genome editing
* Potential for breakthrough discoveries in genetic research
* Enhanced capabilities for gene therapy and biotechnology applications

'''Commercial Applications:'''
The CRISPR transient expression construct (CTEC) has significant commercial potential in the biotechnology and pharmaceutical industries for developing novel therapies and products.

'''Questions about CRISPR Transient Expression Construct (CTEC):'''
1. How does the CTEC technology improve genome editing efficiency?
2. What are the potential limitations of using CTEC in genome editing applications?


==Original Abstract Submitted==

the present invention relates to the field of molecular biology and cell biology. more specifically, the present invention relates to a crispr transient expression construct (ctec) for a genome editing system.



[[Category:C12N15/11]]
[[Category:C12N9/22]]
[[Category:C12N15/81]]
[[Category:CPC_C12N15/11]]